Clinical Characteristics and Decompensation in Patients with Liver Cirrhosis Treated at Two Hepatology Centers in Bogota DC from 2010 To 2014

Authors

  • Jhon E Prieto O Clínica Universitaria Colombia
  • Santiago Sánchez P Clínica Universitaria Colombia
  • Robin G Prieto Clínica Universitaria Colombia
  • Ever L Rojas D Clínica Universitaria Colombia
  • Lupita González Centro de enfermedades hepáticas y digestivas
  • Fredy Mendivelso Clínica Reina Sofía

DOI:

https://doi.org/10.22516/25007440.66

Keywords:

Gastroenterology, liver cirrhosis, ascites, hepatitis non-alcoholic steatohepatitis (NASH)

Abstract

Introduction: Cirrhosis is the final medical condition of various progressive liver disease. Its prevalence varies from one country to another. Currently alcohol abuse, non-alcoholic fatty liver disease and chronic viral hepatitis are mentioned as the main causes. In our centers we have no clinical studies regarding this disease. Materials and Methods: This is a retrospective, descriptive study of the clinical histories of patients who were diagnosed with liver cirrhosis between January 1, 2010 to March 31, 2014. Results: The study included 419 patients, 50.1% of whom were women and 49.9% of whom were men. The average age at diagnosis of cirrhosis 63 years. 73% of patients had physical findings of chronic liver disease and 27% had normal physical examinations. The main etiologies in this series were nonalcoholic steatohepatitis (25.5%), alcoholic cirrhosis (14.8%), hepatitis C infection (14.6%), autoimmune cirrhosis (10%), nonalcoholic steatohepatitis plus alcohol (6.7%),  and others (14.6%). The Child-Pugh classification could be calculated in 394 patients. Of these 59.1% were classified A, 32.4% were classified B, and 8.3% were classified C. The primary reasons for decompensation ascites (36.1%), bleeding varices (28.4%) and hepatocellular carcinoma (15.3%). Conclusions: Local epidemiological behavior does not differ from those found elsewhere in the  world. Attention needs to be paid to detection in early stages and NASH as the main etiological factor.

Downloads

Download data is not yet available.

Languages:

es

References

Tsochatzis EA, Bosch J, Burroughs AK. Liver cirrhosis. Lancet. 2014;383(9930):1749-61.

Lefton HB, Rosa A, Cohen M. Diagnosis and epidemiology of cirrhosis. Med Clin North Am. 2009;93:787-99

Hatzakis A, Wait S, Bruix J, Buti M, Carballo M, Cavaleri M, et al. The state of hepatitis B and C in Europe: Report from the hepatitis B and C summit conference. J Viral Hepat. 2011:18Suppl1:1-16.

Anthony PP, Ishak KG, Nayak NC, Poulsen HE, Scheuer PJ, Sobin LH. The morphology of cirrhosis. Recommendations on definition, nomenclature, and classification by a working group sponsored by the World Health Organization. J Clin Pathol. 1978;31: 395-414.

Lee UE, Friedman SL. Mechanisms of hepatic fibrogenesis. Best Pract Res Clin Gastroenterol. 2011;25:195-206.

Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134:1655-69.

García-Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology. 2010;51:1445-9.

Desmet VS, Roskams T. Cirrhosis reversal: A duel between dogma and myth. J Hepatol. 2004;40:860-7.

Friedman SL, Bansal MB. Reversal of hepatic fibrosis-fact or fantasy? Hepatology. 2006;43(2)Suppl1:S82-8.

Benvegnù L, Gios M, Boccato S, Alberti A. Natural history of compensated viral cirrhosis: A prospective study on the incidence and hierarchy of major complications. Gut. 2004;53:744-9.

Asrani SK, Kamath PS. Natural history of cirrhosis. Curr Gastroenterol Rep. 2013 Feb;15(2):308.

D’Amico G, García-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies. J Hepatol. 2006;44:217-31.

Schuppan D, Afdhal NH: Liver cirrhosis. Lancet. 2008; 371:838–51.

D’Amico G, Pagliaro L, Bosch J. Pharmacological treatment of portal hypertension: An evidence-based approach. Semin Liver Dis. 1999;19:475-505.

Nusrat S, Khan MS, Fazili J, Madhoun MF. Cirrhosis and its complications: Evidence based treatment. World J Gastroenterol. 2014 May 14;20(18):5442-60.

Starr SP, Raines D. Cirrhosis: Diagnosis, management, and prevention. Am Fam Physician. 2011; Dec 15;84(12):1353-9.

Parkin DM, Bray F, Ferlay J, and Pisani P. Estimating the world cancer burden: Globocan 2000. Int J Cancer. 2001;94:2:153–6.

Bruix J and Sherman M. Management of hepatocellular carcinoma. Hepatology, 2005; 42, 5,1208–36.

White DL, Kanwal F, El-Serag HB. Association between nonalcoholic fatty liver disease and risk for hepatocellular cancer, based on systematic review. Clin Gastroenterol Hepatol. 2012;10:1342.

Bruix J. Hepatocellular carcinoma: Paving the road for further developments. Bruix J. Semin Liver Dis. 2014;Nov;34(4):361.

Child, CG, Turcotte, JG. Surgery and portal hypertension. In: The Liver and Portal Hypertension, Child, CG (Ed), Saunders, Philadelphia 1964. p.50.

Pugh RN, Murray-Lyon IM, Dawson JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973; 60:646.

Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464.

Brunt, EM. Nonalcoholic steatohepatitis: Definition and pathology. Semin Liver Dis. 2001;21:3.

Brunt, EM. Pathology of fatty liver disease. Mod Pathol. 2007; 20 Suppl 1:S40.

Chalasani N, Younossi Z, Lavine JE, Diehl AM, Brunt EM, Cusi K, Charlton M, Sanyal AJ. The diagnosis and management of non-alcoholic fatty liver disease: Practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology. Gastroenterology. 2012;142(7):1592.

Louie K, St Laurent S, Forssen U, Mundy L Piementa J. The high comorbidity burden of the hepatitis C virus infected population in the United States. BMC Infectious Disease. 2012;1286

Aman W, Mousa S, Shiha G, Mousa S. Current status and future directions in the management of chronic hepatitis C. Virology J. 2012, Marzo 2, 9:57

Prieto JE, Sánchez S, Rojas L, Huertas S. Hígado graso: aspectos clínicos en un centro de tercer nivel en Bogotá: periodo 2009-2013. Rev Col Gastroenterol. 2014;29(3),247-253.

Prieto JE, Sánchez S, Rojas L, Huertas S. Hepatitis C crónica: aspectos clínicos, serológicos y de tratamiento en dos centros de atención en Bogotá, Colombia. Rev Col Gastroenterol, 2014,29 (4),424-432.

Al Knawy B, Shiffman M. Percutaneous liver biopsy in clinical practice. Liver Int. 2007 Nov;27(9):1166-73.

Brunt EM. Nonalcoholic fatty liver disease: What the pathologist can tell the clinician. Dig Dis. 2012;30 Suppl 1:61-8.

Law K Brunt EM. Nonalcoholic fatty liver disease. Clin Liver Dis. 2010 Nov;14(4):591-604.

Published

2016-03-30

How to Cite

Prieto O, J. E., Sánchez P, S., Prieto, R. G., Rojas D, E. L., González, L., & Mendivelso, F. (2016). Clinical Characteristics and Decompensation in Patients with Liver Cirrhosis Treated at Two Hepatology Centers in Bogota DC from 2010 To 2014. Revista Colombiana De Gastroenterología, 31(1), 1–8. https://doi.org/10.22516/25007440.66

Issue

Section

Originals articles

Altmetric

Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views
QR Code

Some similar items: